X-132077438-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_194277.3(FRMD7):c.*434C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0172 in 139,696 control chromosomes in the GnomAD database, including 68 homozygotes. There are 639 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.021 ( 66 hom., 624 hem., cov: 23)
Exomes 𝑓: 0.0021 ( 2 hom. 15 hem. )
Consequence
FRMD7
NM_194277.3 3_prime_UTR
NM_194277.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0510
Genes affected
FRMD7 (HGNC:8079): (FERM domain containing 7) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of neuron projection development. Predicted to act upstream of or within several processes, including negative regulation of stress fiber assembly; positive regulation of lamellipodium assembly; and positive regulation of small GTPase mediated signal transduction. Located in cytosol; nucleoplasm; and plasma membrane. Implicated in congenital nystagmus 1. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant X-132077438-G-A is Benign according to our data. Variant chrX-132077438-G-A is described in ClinVar as [Benign]. Clinvar id is 367903.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0699 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRMD7 | NM_194277.3 | c.*434C>T | 3_prime_UTR_variant | 12/12 | ENST00000298542.9 | NP_919253.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRMD7 | ENST00000298542 | c.*434C>T | 3_prime_UTR_variant | 12/12 | 1 | NM_194277.3 | ENSP00000298542.3 | |||
FRMD7 | ENST00000370879 | c.*434C>T | 3_prime_UTR_variant | 8/8 | 1 | ENSP00000359916.1 |
Frequencies
GnomAD3 genomes AF: 0.0209 AC: 2338AN: 112003Hom.: 66 Cov.: 23 AF XY: 0.0182 AC XY: 623AN XY: 34187
GnomAD3 genomes
AF:
AC:
2338
AN:
112003
Hom.:
Cov.:
23
AF XY:
AC XY:
623
AN XY:
34187
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00213 AC: 59AN: 27638Hom.: 2 Cov.: 0 AF XY: 0.00280 AC XY: 15AN XY: 5366
GnomAD4 exome
AF:
AC:
59
AN:
27638
Hom.:
Cov.:
0
AF XY:
AC XY:
15
AN XY:
5366
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0209 AC: 2339AN: 112058Hom.: 66 Cov.: 23 AF XY: 0.0182 AC XY: 624AN XY: 34252
GnomAD4 genome
AF:
AC:
2339
AN:
112058
Hom.:
Cov.:
23
AF XY:
AC XY:
624
AN XY:
34252
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Nystagmus 1, congenital, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at